Northwestern Mutual Wealth Management Co. increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 145.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 314,224 shares of the exchange traded fund’s stock after purchasing an additional 186,314 shares during the quarter. Northwestern Mutual Wealth Management Co. owned 0.48% of SPDR S&P Biotech ETF worth $49,726,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently modified their holdings of the company. Axiom Investment Management LLC bought a new stake in SPDR S&P Biotech ETF in the 1st quarter worth about $26,000. Financial Life Planners bought a new position in SPDR S&P Biotech ETF during the 1st quarter valued at about $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $30,000. Finally, SHP Wealth Management bought a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $31,000.
SPDR S&P Biotech ETF Stock Up 0.6%
XBI opened at $163.40 on Wednesday. The stock has a market capitalization of $10.67 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. The firm has a 50 day moving average price of $157.44 and a 200-day moving average price of $139.75. SPDR S&P Biotech ETF has a twelve month low of $91.10 and a twelve month high of $169.89.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
